Trial Profile
A Randomised, Double-blind, Placebo-controlled, Proof-of-mechanism Phase 2 Trial Investigating the Effect of Quinagolide Extended-release Vaginal Ring on Reduction of Lesions Assessed by High-resolution Magnetic Resonance Imaging in Women With Endometrioma, Deep Infiltrating Endometriosis, and/or Adenomyosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2022
Price :
$35
*
At a glance
- Drugs Quinagolide (Primary)
- Indications Adenomyosis; Endometriosis
- Focus Therapeutic Use
- Acronyms QLARITY
- Sponsors Ferring Pharmaceuticals
- 03 Aug 2021 Status changed from active, no longer recruiting to completed.
- 07 Jul 2021 This trial has been completed in Germany, according to European Clinical Trials Database
- 01 Jul 2021 This trial has been completed in Denmark, according to European Clinical Trials Database.